The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Open accessAbstract
Intrahepatic cholangiocarcinoma (iCCA) has over the last 10‐20 years become the focus of increasing concern, largely due to its rising incidence and high mortality rates worldwide. The significant increase in mortality rates from this primary hepatobiliary cancer, particularly over the past decade, has coincided with a rapidly growing interest among clinicians, investigators, and patient advocates to seek greater mechanistic insights and more effective biomarker‐driven targeted approaches for managing and/or preventing this challenging liver cancer. In addition to discussing challenges posed by this aggressive cancer, this review will emphasize recent epidemiological, basic, and translational research findings for iCCA. In particular, we will highlight emerging demographic changes and evolving risk factors, the critical role of the tumor microenvironment, extracellular vesicle biomarkers and therapeutics, intertumoral and intratumoral heterogeneity, and current and emerging targeted therapies regarding iCCA. Specifically, recent evidence linking non–bile duct medical conditions, such as nonalcoholic fatty liver disease and nonspecific cirrhosis, to intrahepatic cholangiocarcinogenesis together with geographic and ethnic variation will be assessed. Recent developments concerning the roles played by transforming growth factor‐β and platelet‐derived growth factor D in driving the recruitment and expansion of cancer‐associated myofibroblasts within cholangiocarcinoma (CCA) stroma as well as their therapeutic implications will also be discussed. In addition, the potential significance of extracellular vesicles as bile and serum biomarkers and therapeutic delivery systems for iCCA will be described. An integrated systems approach to classifying heterogeneous iCCA subtypes will be further highlighted, and recent clinical trials and emerging targeted therapies will be reviewed, along with recommendations for future translational research opportunities. Established international CCA networks are now facilitating collaborations aimed at advancing iCCA translational and clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
Tran, E., Turcotte, S., Gros, A., Robbins, P. F., Lu, Y.-C., Dudley, M. E., Wunderlich, J. R., Somerville, R. P., Hogan, K., Hinrichs, C. S., et al. (2014) · Science · doi:10.1126/science.1251102 · Cited by 1,718
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationGuidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Self-citationGenomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Jusakul, A., Cutcutache, I., Yong, C. H., Lim, J. Q., Huang, M. N., Padmanabhan, N., Nellore, V., Kongpetch, S., Ng, A. W. T., Ng, L. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0368 · Cited by 969
Mavros, M. N., Economopoulos, K. P., Alexiou, V. G., & Pawlik, T. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.5137 · Cited by 808
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Saha, S. K., Zhu, A. X., Fuchs, C. S., & Brooks, G. A. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0446 · Cited by 786
Self-citationThe Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Self-citationPhase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Javle, M., Lowery, M., Shroff, R. T., Weiss, K. H., Springfeld, C., Borad, M. J., Ramanathan, R. K., Goyal, L., Sadeghi, S., Macarulla, T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.5009 · Cited by 693
Self-citationEpidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Massarweh, N. N., & El-Serag, H. B. (2017) · Cancer Control · doi:10.1177/1073274817729245 · Cited by 634
Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K., & Szabo, G. (2012) · Hepatology · doi:10.1002/hep.25873 · Cited by 631
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Goyal, L., Saha, S. K., Liu, L. Y., Siravegna, G., Leshchiner, I., Ahronian, L. G., Lennerz, J. K., Vu, P., Deshpande, V., Kambadakone, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1000 · Cited by 552
Self-citationCommon Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434
Self-citationSingle‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Zheng, H., Pomyen, Y., Hernandez, M. O., Li, C., Livak, F., Tang, W., Dang, H., Greten, T. F., Davis, J. L., Zhao, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29778 · Cited by 349
Arbelaiz, A., Azkargorta, M., Krawczyk, M., Santos‐Laso, A., Lapitz, A., Perugorria, M. J., Erice, O., Gonzalez, E., Jimenez‐Agüero, R., Lacasta, A., et al. (2017) · Hepatology · doi:10.1002/hep.29291 · Cited by 289
Self-citationIsocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Self-citationMolecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Moeini, A., Sia, D., Bardeesy, N., Mazzaferro, V., & Llovet, J. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3296 · Cited by 240
Li, L., Masica, D., Ishida, M., Tomuleasa, C., Umegaki, S., Kalloo, A. N., Georgiades, C., Singh, V. K., Khashab, M., Amateau, S., et al. (2014) · Hepatology · doi:10.1002/hep.27050 · Cited by 223
Self-citationDesmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting
Sirica, A. E., & Gores, G. J. (2014) · Hepatology · doi:10.1002/hep.26762 · Cited by 217
Self-citationTherapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Mertens, J. C., Fingas, C. D., Christensen, J. D., Smoot, R. L., Bronk, S. F., Werneburg, N. W., Gustafson, M. P., Dietz, A. B., Roberts, L. R., Sirica, A. E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2130 · Cited by 212
Self-citationIdentification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
Woo, H. G., Lee, J.-H., Yoon, J.-H., Kim, C. Y., Lee, H.-S., Jang, J. J., Yi, N.-J., Suh, K.-S., Lee, K. U., Park, E. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2823 · Cited by 190
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
Sirica, A. E. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.222 · Cited by 188
Self-citationCadamuro, M., Nardo, G., Indraccolo, S., Dall'Olmo, L., Sambado, L., Moserle, L., Franceschet, I., Colledan, M., Massani, M., Stecca, T., et al. (2013) · Hepatology · doi:10.1002/hep.26384 · Cited by 175
Self-citationLi, L., Piontek, K., Ishida, M., Fausther, M., Dranoff, J. A., Fu, R., Mezey, E., Gould, S. J., Fordjour, F. K., Meltzer, S. J., et al. (2016) · Hepatology · doi:10.1002/hep.28735 · Cited by 142
Self-citationBorger, D. R., Goyal, L., Yau, T., Poon, R. T., Ancukiewicz, M., Deshpande, V., Christiani, D. C., Liebman, H. M., Yang, H., Kim, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2649 · Cited by 138
Self-citationClapéron, A., Mergey, M., Aoudjehane, L., Ho-Bouldoires, T. H. N., Wendum, D., Prignon, A., Merabtene, F., Firrincieli, D., Desbois‐Mouthon, C., Scatton, O., et al. (2013) · Hepatology · doi:10.1002/hep.26585 · Cited by 112
Murakami, Y., Kubo, S., Tamori, A., Itami, S., Kawamura, E., Iwaisako, K., Ikeda, K., Kawada, N., Ochiya, T., & Taguchi, Y. (2015) · Scientific Reports · doi:10.1038/srep16294 · Cited by 101
Antwi, S. O., Mousa, O. Y. S., & Patel, T. C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.0929 · Cited by 100
Lowery, M. A., Abou‐Alfa, G. K., Burris, H. A., Jankú, F., Shroff, R. T., Cleary, J. M., Azad, N. S., Goyal, L., Maher, E. A., Gore, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.4015 · Cited by 96
Self-citationLoeffler, M. W., Chandran, P. A., Laske, K., Schroeder, C., Bonzheim, I., Walzer, M., Hilke, F. J., Trautwein, N., Kowalewski, D. J., Schuster, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.027 · Cited by 93
Ling, H., Roux, E., Hempel, D. M., Tao, J., Smith, M. M., Lonning, S. M., Zuk, A., ARBEENY, C. M., & Ledbetter, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054499 · Cited by 83
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma
Cadamuro, M., Stecca, T., Brivio, S., Mariotti, V., Fiorotto, R., Spirlì, C., Strazzabosco, M., & Fabris, L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.028 · Cited by 81
Self-citationAltekruse, S. F., Petrick, J. L., Rolin, A. I., Cucinelli, J. E., Zou, Z., Tatalovich, Z., & McGlynn, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120574 · Cited by 79
Thanee, M., Loilome, W., Techasen, A., Namwat, N., Boonmars, T., Pairojkul, C., & Yongvanit, P. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.3043 · Cited by 75
Mu, X., Pradère, J., Affò, S., Dapito, D. H., Friedman, R. A., Lefkowitch, J. H., & Schwabe, R. F. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.039 · Cited by 66
Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
Ilyas, S. I., Mertens, J. C., Bronk, S. F., Hirsova, P., Dai, H., Roberts, L. R., Kaufmann, S. H., & Gores, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563064 · Cited by 61
Self-citationAntwi, S. O., Mousa, O. Y. S., & Patel, T. C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8659 · Cited by 50
Merdrignac, A., Angenard, G., Allain, C., Petitjean, K., Bergeat, D., Bellaud, P., Fautrel, A., Turlin, B., Clément, B., Dooley, S., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1142 · Cited by 49
The Biological and Clinical Challenge of Liver Cancer Heterogeneity
Wang, X. W., & Thorgeirsson, S. S. (2014) · Hepatic Oncology · doi:10.2217/hep.14.18 · Cited by 40
Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression
Huang, C., Aihara, A., Iwagami, Y., Yu, T., Carlson, R. I., Koga, H., Kim, M., Zou, J., Casulli, S., & Wands, J. R. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.038 · Cited by 36
Surveillance in cholangiocellular carcinoma
Wirth, T. C., & Vogel, A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.11.001 · Cited by 30
Jesper, D., Heyn, S. G., Schellhaas, B., Pfeifer, L., Goertz, R. S., Zopf, S., Neurath, M. F., & Strobel, D. D. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001036 · Cited by 27
Manzanares, M. Á., Usui, A., Campbell, D. J. W., Dumur, C. I., Maldonado, G. T., Fausther, M., Dranoff, J. A., & Sirica, A. E. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.013 · Cited by 23
Self-citation
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationBrindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Self-citationChen, Q., Wang, H., Li, Z., Li, F., Liang, L., Zou, Y., Shen, H., Li, J., Xia, Y., Cheng, Z., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.027 · Cited by 296
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Qu, J., Yan, H., Hou, Y., Cao, W., Liu, Y., Zhang, E., He, J., & Cai, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01224-4 · Cited by 260
The tumour microenvironment and immune milieu of cholangiocarcinoma
Fabris, L., Perugorria, M. J., Mertens, J., Björkström, N. K., Cramer, T., Lleo, A., Solinas, A., Sänger, H., Lukacs‐Kornek, V., Moncsek, A., et al. (2019) · Liver International · doi:10.1111/liv.14098 · Cited by 187
Self-citation
Metadata
- Authors
- Sirica, A. E., Gores, G. J., Groopman, J. D., Selaru, F. M., Strazzabosco, M., Wei Wang, X., & Zhu, A. X.
- Venue
- Hepatology
- Published
- 2019-03-25
- Volume
- 69
- Issue
- 4
- Pages
- 1803-1815
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2892899495
- Cited by
- 315
- References
- 47
- FWCI
- 24.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.